These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17920256)

  • 1. Improvements with tiotropium in COPD patients with concomitant asthma.
    Magnussen H; Bugnas B; van Noord J; Schmidt P; Gerken F; Kesten S
    Respir Med; 2008 Jan; 102(1):50-6. PubMed ID: 17920256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized study of tiotropium Respimat Soft Mist inhaler vs. ipratropium pMDI in COPD.
    Voshaar T; Lapidus R; Maleki-Yazdi R; Timmer W; Rubin E; Lowe L; Bateman E
    Respir Med; 2008 Jan; 102(1):32-41. PubMed ID: 17996436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of tiotropium inhalation capsules and ipratropium metered dose inhaler in a randomized, double-blind, double-dummy, efficacy and safety study in patients with chronic obstructive pulmonary disease].
    Zheng JP; Kang J; Cai BQ; Zhou X; Cao ZL; Bai CX; Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jun; 29(6):363-7. PubMed ID: 17045014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
    Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M;
    N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial.
    Kerstjens HA; Disse B; Schröder-Babo W; Bantje TA; Gahlemann M; Sigmund R; Engel M; van Noord JA
    J Allergy Clin Immunol; 2011 Aug; 128(2):308-14. PubMed ID: 21636120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group.
    Casaburi R; Briggs DD; Donohue JF; Serby CW; Menjoge SS; Witek TJ
    Chest; 2000 Nov; 118(5):1294-302. PubMed ID: 11083677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A one-year trial of tiotropium Respimat plus usual therapy in COPD patients.
    Bateman ED; Tashkin D; Siafakas N; Dahl R; Towse L; Massey D; Pavia D; Zhong NS
    Respir Med; 2010 Oct; 104(10):1460-72. PubMed ID: 20620037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial.
    Tashkin DP; Littner M; Andrews CP; Tomlinson L; Rinehart M; Denis-Mize K
    Respir Med; 2008 Apr; 102(4):479-87. PubMed ID: 18258423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium.
    Donohue JF; Fogarty C; Lötvall J; Mahler DA; Worth H; Yorgancioglu A; Iqbal A; Swales J; Owen R; Higgins M; Kramer B;
    Am J Respir Crit Care Med; 2010 Jul; 182(2):155-62. PubMed ID: 20463178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
    Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
    Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study.
    Vogelmeier C; Kardos P; Harari S; Gans SJ; Stenglein S; Thirlwell J
    Respir Med; 2008 Nov; 102(11):1511-20. PubMed ID: 18804362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD.
    van Noord JA; Aumann JL; Janssens E; Verhaert J; Smeets JJ; Mueller A; Cornelissen PJ
    Chest; 2006 Mar; 129(3):509-17. PubMed ID: 16537846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COPD in young patients: a pre-specified analysis of the four-year trial of tiotropium (UPLIFT).
    Morice AH; Celli B; Kesten S; Lystig T; Tashkin D; Decramer M
    Respir Med; 2010 Nov; 104(11):1659-67. PubMed ID: 20724131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease.
    Littner MR; Ilowite JS; Tashkin DP; Friedman M; Serby CW; Menjoge SS; Witek TJ
    Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1136-42. PubMed ID: 10764302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained 24-h efficacy of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patients.
    Verkindre C; Fukuchi Y; Flémale A; Takeda A; Overend T; Prasad N; Dolker M
    Respir Med; 2010 Oct; 104(10):1482-9. PubMed ID: 20541381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease.
    Tashkin DP; Hanania NA; McGinty J; Denis-Mize K; Chaudry I
    Adv Ther; 2009 Nov; 26(11):1024-34. PubMed ID: 19953349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative use of inhaled tiotropium in lung cancer patients with untreated COPD.
    Kobayashi S; Suzuki S; Niikawa H; Sugawara T; Yanai M
    Respirology; 2009 Jul; 14(5):675-9. PubMed ID: 19476597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial.
    Troosters T; Celli B; Lystig T; Kesten S; Mehra S; Tashkin DP; Decramer M;
    Eur Respir J; 2010 Jul; 36(1):65-73. PubMed ID: 20185426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A randomized, double-blind, placebo-control study of once-daily inhaled tiotropium in chronic obstructive pulmonary disease].
    Yin KS; Zhang DP; Shi Y; Sun LH; Min R; Xiao YL; Xia XR; Tan Y; Fu WZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jul; 33(7):519-23. PubMed ID: 20979799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.